All Drugs Associated with Nephrotic syndrome
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
312 drugs have been associated with Nephrotic syndrome in FAERS reports.
| Drug | Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|
| MYCOPHENOLATE MOFETIL | 302 | 10 | 73 | 4 |
| BEVACIZUMAB | 279 | 28 | 105 | 18 |
| TACROLIMUS | 251 | 6 | 88 | 7 |
| RITUXIMAB | 244 | 15 | 38 | 6 |
| PREDNISONE | 242 | 10 | 65 | 12 |
| CYCLOSPORINE | 185 | 13 | 52 | 7 |
| PREDNISOLONE | 181 | 12 | 83 | 9 |
| LANSOPRAZOLE | 145 | 19 | 43 | 2 |
| CYCLOPHOSPHAMIDE | 143 | 17 | 52 | 7 |
| METHYLPREDNISOLONE | 141 | 17 | 59 | 6 |
| LENVATINIB | 137 | 11 | 84 | 3 |
| NIVOLUMAB | 137 | 12 | 62 | 8 |
| OMEPRAZOLE | 137 | 22 | 42 | 5 |
| PANTOPRAZOLE | 134 | 16 | 45 | 3 |
| METHOTREXATE | 113 | 12 | 51 | 5 |
| ESOMEPRAZOLE | 106 | 14 | 31 | 3 |
| PEMBROLIZUMAB | 105 | 10 | 61 | 21 |
| IBUPROFEN | 95 | 0 | 58 | 5 |
| DICLOFENAC | 91 | 0 | 64 | 0 |
| RAMUCIRUMAB | 82 | 4 | 49 | 6 |
| ADALIMUMAB | 78 | 2 | 32 | 0 |
| ATEZOLIZUMAB | 78 | 3 | 42 | 2 |
| AMLODIPINE | 75 | 3 | 22 | 4 |
| DEXAMETHASONE | 74 | 13 | 39 | 4 |
| PAZOPANIB | 72 | 10 | 19 | 1 |
| CARBOPLATIN | 70 | 1 | 38 | 18 |
| PACLITAXEL | 64 | 1 | 25 | 15 |
| CABOZANTINIB S-MALATE | 60 | 6 | 15 | 3 |
| FUROSEMIDE | 60 | 3 | 45 | 8 |
| OXALIPLATIN | 58 | 5 | 28 | 5 |
| FLUOROURACIL | 56 | 4 | 27 | 5 |
| NAPROXEN | 53 | 0 | 41 | 0 |
| EVEROLIMUS | 52 | 6 | 25 | 0 |
| IPILIMUMAB | 52 | 5 | 22 | 2 |
| HYDROXYCHLOROQUINE | 48 | 0 | 4 | 0 |
| AZATHIOPRINE | 47 | 6 | 14 | 2 |
| CAPECITABINE | 47 | 5 | 10 | 5 |
| ETANERCEPT | 46 | 2 | 26 | 0 |
| IRINOTECAN | 46 | 3 | 21 | 2 |
| GEMCITABINE | 45 | 1 | 32 | 3 |
| BELIMUMAB | 43 | 0 | 7 | 2 |
| BORTEZOMIB | 43 | 5 | 21 | 2 |
| DAPAGLIFLOZIN | 41 | 0 | 12 | 1 |
| LEUCOVORIN | 41 | 4 | 16 | 3 |
| RAMIPRIL | 41 | 0 | 17 | 5 |
| AXITINIB | 40 | 9 | 14 | 1 |
| CORTICOTROPIN | 40 | 1 | 20 | 0 |
| DASATINIB | 40 | 2 | 11 | 3 |
| IMATINIB | 39 | 7 | 16 | 2 |
| LENALIDOMIDE | 39 | 3 | 20 | 0 |